Skip to main content

Table 1 Characteristics of study subjects according to the presence of two or more metabolic risk factors except WC in elderly Koreans

From: The cutoff values of visceral fat area and waist circumference for identifying subjects at risk for metabolic syndrome in elderly Korean: Ansan Geriatric (AGE) cohort study

  

Men

 

Women

 

Total

Two or more metabolic risk factors of the modified NCEP-ATP III of the criteria except WC

Total

Two or more metabolic risk factors of the modified NCEP-ATP III of the criteria except WC

  

Absent

Present

 

Absent

Present

N (%)

308

105 (34.1)

203 (65.9)

381

101 (26.5)

280 (73.5)

Age (years)

71.2 ± 5.2

70.6 ± 5.1

71.6 ± 5.3

70.5 ± 4.7

70.5 ± 5.0

70.5 ± 4.7

Body mass index (kg/m2)

24.0 ± 2.8

22.6 ± 2.4

24.7 ± 2.7*

25.0 ± 3.1†

23.4 ± 3.4

25.6 ± 2.8*

Waist circumference (cm)

88.0 ± 7.6

83.9 ± 7.0

90.2 ± 7.0*

88.5 ± 8.3

84.6 ± 9.1

90.0 ± 7.5*

VFA (cm2)

103.6 ± 49.1

78.3 ± 40.4

116.7 ± 48.2*

108.9 ± 45.4

84.0 ± 37.5

117.9 ± 44.7*

SFA (cm2)

157.1 ± 50.9

138.6 ± 47.5

166.7 ± 50.1*

239.4 ± 67.8†

215.5 ± 74.9

248.0 ± 63.0*

Fasting glucose (mg/dl)

96.5 ± 17.0

90.0 ± 8.9

99.8 ± 19.0*

95.8 ± 21.1

88.1 ± 10.6

98.5 ± 23.1*

post 2 hr OGTT-glucose (mg/dl)

129.5 ± 50.8

103.7 ± 34.0

145.5 ± 52.9*

138.5 ± 51.7

109.1 ± 27.2

150.9 ± 54.5

High glucose (n, (%))a

151 (49.0)

15 (14.3)

136 (67.0)*

187 (49.1)

10 (9.9)

177 (63.2)*

Taking oral hypoglycemic medication or insulin (n,(%))

41(13.3)

3 (2.9)

38 (18.7)*

44 (13.6)

3 (3.0)

41 (14.6)*

Systolic blood pressure

129.4 ± 15.6

123.2 ± 16.2

132.6 ± 14.3*

127.3 ± 16.1

120.0 ± 13.4

129.9 ± 16.2*

Diastolic blood pressure

76.1 ± 8.5

73.9 ± 7.5

77.3 ± 8.7*

75.2 ± 8.0

72.1 ± 8.1

76.3 ± 7.7*

High blood pressure (n, (%))b

205 (66.6)

35 (33.3)

170 (83.7)*

249 (65.4)

35 (34.7)

214 (76.4)*

Taking antihypertensive medication (n, (%))

140(45.5)

20 (19.1)

120 (59.2)*

185 (48.6)

21 (20.8)

164 (58.6)*

Triglycerides (mg/dl)

137.1 ± 80.9

97.9 ± 29.3

157.4 ± 91.0*

146.5 ± 80.9

92.2 ± 26.9

166.0 ± 84.9*

Hypertriglyceridemia (n, (%))c

96 (31.2)

5 (4.8)

91 (44.8)*

138 (36.2)

1 (1.0)

137 (48.9)*

HDL cholesterol (mg/dl)

41.0 ± 10.2

46.8 ± 9.4

38.1 ± 9.2*

43.1 ± 10.4†

51.6 ± 9.8

40.0 ± 8.8*

Low HDL cholesterol (n,(%))d

159 (51.6)

16 (15.2)

143 (70.4)*

286 (75.1)†

39 (38.6)

247 (88.2)*

Taking lipid-lowering medication (n, (%))

31 (10.1)

8 (7.6)

23 (11.3)

44 (11.6)

10 (9.9)

34 (12.1)

  1. Data are mean ± S.D. or %. VFA, Visceral abdominal fat area; SFA, Subcutaneous abdominal fat area
  2. aHigh glucose was diagnosed if fasting glucose ≥100 mg/dl or post 2 hr OGTT-glucose ≥140 mg/dl or the subjects with oral hypoglycemic medication or insulin.
  3. bHigh blood pressure was diagnosed if systolic blood pressure was ≥130 mmHg, diastolic blood pressure ≥85 mmHg, or the subjects with antihypertensive medications.
  4. cHypertriglyceridemia was diagnosed if triglycerides was ≥150 mg/dl in men and women.
  5. dLow HDL cholesterol was diagnosed if HDL cholesterol was < 40 mg/dl in men and < 50 mg/dl in women.
  6. *: p <0.01 compared with subjects without two or more metabolic risk factors in each gender.
  7. †: p < 0.01 compared with men.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us